Zobrazeno 1 - 10
of 74
pro vyhledávání: '"James W Langston"'
Autor:
Julie Doostzadeh, Shadi Shokralla, Farnaz Absalan, Roxana Jalili, Sharareh Mohandessi, James W Langston, Ronald W Davis, Mostafa Ronaghi, Baback Gharizadeh
Publikováno v:
PLoS ONE, Vol 3, Iss 7, p e2693 (2008)
Pyrosequencing is a DNA sequencing method based on the principle of sequencing-by-synthesis and pyrophosphate detection through a series of enzymatic reactions. This bioluminometric, real-time DNA sequencing technique offers unique applications that
Externí odkaz:
https://doaj.org/article/de2d766b03d844a1b5f8cf27e3cfe9c8
Autor:
Rita Gandhy, James W Langston, Rohit Dhall, Linda Rees, Salima Brillman, Carrolee Barlow, Anthony Santiago
Publikováno v:
Journal of Parkinson's Disease
Background Wearable sensors provide accurate, continuous objective measurements, quantifying the variable motor states of patients with Parkinson's disease (PD) in real time. Objectives To evaluate the impact of using continuous objective measurement
Autor:
Michael A. Schwarzschild, Paul English, Sarah A. Jewell, John E. Duda, Donato DiMonte, Bill Scott, G. W. Ross, Jeff M. Bronstein, Deborah A. Cory-Slechta, Giancarlo Logroscino, Stephen J. Grate, Honglei Chen, James W. Langston, Richard F. Seegal, Lorene M. Nelson, Stephen K. Van Den Eeden, Paul M. Carvey, Walter J. Koroshetz, Jane A. Hoppin, Walter A. Rocca, Caroline M. Tanner, Bernard Ravina, Johnni Hansen, Samuel M. Goldman, Freya Kamel, Ted Schettler, Andrew B. Singleton, Kyle Steenland, Marc G. Weisskopf
Publikováno v:
Environmental Health Perspectives
Background Parkinson’s disease (PD) is the second most common neurodegenerative disorder. People with PD, their families, scientists, health care providers, and the general public are increasingly interested in identifying environmental contributor
Publikováno v:
Toxicological Sciences. 95:182-187
The yeast deletion collection includes approximately 4700 strains deleted for both copies of every nonessential gene. This collection is a powerful resource for identifying the cellular pathways that functionally interact with drugs. In the present s
Autor:
Robert W. Butler, James W. Langston, Raymond K. Mulhern, Ping Zou, Chin-Shang Li, Robert J. Ogg
Publikováno v:
NeuroImage. 24:61-69
Children surviving certain cancers have a high incidence of cognitive deficits caused by central nervous system (CNS) disease or treatments directed at the CNS. To establish the feasibility of using blood oxygen level-dependent (BOLD) functional magn
Autor:
Shawna L. Palmer, James W. Langston, S. Wu, Xiaoping Xiong, Raymond K. Mulhern, Wilburn E. Reddick, John O. Glass, Larry E. Kun, Amar Gajjar
Publikováno v:
Neuro-Oncology. 7:12-19
Brain tumors constitute approximately 20% of pediatric malignancies. Because of the inherent risk of these tumors, patients receive aggressive CNS therapy that often comprises maximal surgical resection, local and craniospinal irradiation (CSI), and
Autor:
Winfred C. Wang, James W. Langston, Gisele M. Hankins, Kathleen J. Helton, R. Grant Steen, Xiaoping Xiong, Kenneth Beil
Publikováno v:
Radiology. 228:208-215
To determine whether sickle cell trait (hemoglobin AS) is associated with abnormalities in the brain of asymptomatic children.Magnetic resonance (MR) imaging and MR angiography were performed prospectively in 26 siblings (eight girls, 18 boys; mean a
Autor:
James W. Langston, Wayne L. Furman, Stephen J. Thompson, Carlos Rodriguez-Galindo, Sue C. Kaste
Publikováno v:
Pediatric Radiology. 30:558-565
There is a paucity of radiologic literature addressing neurologic emergencies in children receiving therapy for non-CNS primary malignancies. In the acute setting, many of these children present to local community hospitals. This pictorial is from a
Autor:
James W. Langston, Richard L. Heideman, David A. Reardon, Stephen Thompson, Amar J. Gajjar, Dana Jones-Wallace, Andrew W. Walter, Larry E. Kun
Publikováno v:
Journal of Pediatric Hematology/Oncology. 22:247-251
Purpose: The authors conducted a single-arm, prospective study using tamoxifen and carboplatin for the treatment of children with progressive or symptomatic low-grade gliomas. Patients and Methods: Fourteen children with consecutively diagnosed cases
Autor:
John O. Glass, June S. Taylor, James W. Langston, Shawna L. Palmer, T. David Elkin, Amar Gajjar, Larry E. Kun, Raymond K. Mulhern, Wilburn E. Reddick
Publikováno v:
Annals of Neurology. 46:834-841
Although previous studies have documented a significant risk of intellectual loss after treatment for childhood medulloblastoma (MED), the pathophysiology underlying this process is poorly understood. The purpose of this study was to test the hypothe